Avalo Therapeutics Inc

Insider buying shows confidence in Avalo Therapeutics’ promising pipeline of AVO‑102, AVO‑204 and AVO‑301, with fast‑track FDA status and robust early safety data.

Insider buying at Avalo Therapeutics shows board confidence in its high‑growth biotech pipeline, highlighting the company’s strategy, competitive edge, and potential upside while noting key risks.